PureTech Health PLC at Barclays Global Healthcare Conference Transcript
Great. Good afternoon, and welcome to Barclays Global Healthcare Conference Day 1. My name is Carter Gould, Senior Biopharma Analyst here at Barclays. It's my pleasure to welcome PureTech to the stage.
Joining us is Bharatt Chowrira, President, CBO, CFO and COO; as well as Eric Elenko, Chief Innovation Officer. Bharatt is going to open up the time here with a brief presentation before we jump into Q&A. Bharatt.
Thanks, Carter, and thanks to the Barclays team for inviting us to present here. For those of you who are not familiar with PureTech, we are based in Boston. We're a biopharmaceutical company. We're fairly unique type of a biopharmaceutical company, and we'll go into a little bit more details as to why we think that way.
We are coming off of a very eventful, successful 2022, where we completed 5 clinical trials. And this year
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
